Boothbay Fund Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.2M Buy
58,307
+33,842
+138% +$5.5M 0.18% 125
2026
Q2
$3.34M Buy
24,465
+5,267
+27% +$647K 0.04% 490
2026
Q1
$2.26M Buy
+19,198
New +$2.68M 0.03% 566
2019
Q4
– Sell
-2,654
Closed -$204K – 962
2019
Q3
$204K Buy
+2,654
New +$232K 0.02% 652

Other funds holding RGEN

Boothbay Fund Management's RGEN Position: Q3 2026 in Review

Boothbay Fund Management increased its Repligen (RGEN) stake by 138% in Q3 2026, buying an estimated $5.5M and bringing the position to 58,307 shares worth $11.2M. The position accounts for 0.18% of the portfolio, ranked #125.

Boothbay Fund Management first reported a position in RGEN in Q3 2019 and has held it in 4 quarters since. 525 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Boothbay Fund Management held 58,307 shares of Repligen worth $11.2M as of Q3 2026.
  • Boothbay Fund Management bought 33,842 Repligen shares in Q3 2026, an estimated $5.5M.
  • Repligen made up 0.18% of Boothbay Fund Management's portfolio in Q3 2026, its #125 holding.
  • Boothbay Fund Management first reported a position in Repligen in Q3 2019 and has held it in 4 quarters since.
  • 525 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.